Rita Rosenthal1, Julia Luettig2, Nina A Hering3, Susanne M Krug2, Uwe Albrecht4, Michael Fromm2, Jörg-Dieter Schulzke2. 1. Department of Gastroenterology, Rheumatology and Infectious Diseases, Section Nutritional Medicine/Clinical Physiology, Charité, Campus Benjamin Franklin, 12200, Berlin, Germany. rita.rosenthal@charite.de. 2. Department of Gastroenterology, Rheumatology and Infectious Diseases, Section Nutritional Medicine/Clinical Physiology, Charité, Campus Benjamin Franklin, 12200, Berlin, Germany. 3. Department of General, Visceral and Vascular Surgery, Charité, Campus Benjamin Franklin, Berlin, Germany. 4. Mediconomics GmbH, Hannover, Germany.
Abstract
PURPOSE: Myrrh, the oleo-gum resin of Commiphora molmol, is well known for its anti-inflammatory properties. In different animal models, it protected against DSS-, TNBS- and oxazolone-induced colitis. To date, no information concerning the effect of myrrh on barrier properties are available. Thus, this study investigates the effect of myrrh on paracellular barrier function in the absence or presence of the pro-inflammatory cytokine TNFα. METHODS: Monolayers of human colon cell lines HT-29/B6 and Caco-2 were incubated with myrrh under control conditions or after challenge with the pro-inflammatory cytokine TNFα. Barrier function was analysed by electrophysiological and permeability measurements, Western blotting, immunostaining in combination with confocal microscopy, and freeze-fracture electron microscopy. RESULTS: In Caco-2 cells, myrrh induced an increase in transepithelial resistance (TER) which was associated with downregulation of the channel-forming tight junction (TJ) protein claudin-2 via inhibition of the PI3 kinase signalling pathway. In HT-29/B6 cells, myrrh had no effect on barrier properties under basic conditions, but protected against barrier damage induced by TNFα, as indicated by a decrease in TER and an increase in fluorescein permeability. The TNFα effect was associated with a redistribution of the sealing TJ protein claudin-1, an increase in the expression of claudin-2 and a change in TJ ultrastructure. Most importantly, all TNFα effects were inhibited by myrrh. The effect of myrrh on claudin-2 expression in this cell line was mediated via inhibition of the STAT6 pathway. CONCLUSIONS: This study shows for the first time that myrrh exerts barrier-stabilising and TNFα-antagonising effects in human intestinal epithelial cell models via inhibition of PI3K and STAT6 signalling. This suggests therapeutic application of myrrh in intestinal diseases associated with barrier defects and inflammation.
PURPOSE:Myrrh, the oleo-gum resin of Commiphora molmol, is well known for its anti-inflammatory properties. In different animal models, it protected against DSS-, TNBS- and oxazolone-induced colitis. To date, no information concerning the effect of myrrh on barrier properties are available. Thus, this study investigates the effect of myrrh on paracellular barrier function in the absence or presence of the pro-inflammatory cytokine TNFα. METHODS: Monolayers of human colon cell lines HT-29/B6 and Caco-2 were incubated with myrrh under control conditions or after challenge with the pro-inflammatory cytokine TNFα. Barrier function was analysed by electrophysiological and permeability measurements, Western blotting, immunostaining in combination with confocal microscopy, and freeze-fracture electron microscopy. RESULTS: In Caco-2 cells, myrrh induced an increase in transepithelial resistance (TER) which was associated with downregulation of the channel-forming tight junction (TJ) protein claudin-2 via inhibition of the PI3 kinase signalling pathway. In HT-29/B6 cells, myrrh had no effect on barrier properties under basic conditions, but protected against barrier damage induced by TNFα, as indicated by a decrease in TER and an increase in fluorescein permeability. The TNFα effect was associated with a redistribution of the sealing TJ protein claudin-1, an increase in the expression of claudin-2 and a change in TJ ultrastructure. Most importantly, all TNFα effects were inhibited by myrrh. The effect of myrrh on claudin-2 expression in this cell line was mediated via inhibition of the STAT6 pathway. CONCLUSIONS: This study shows for the first time that myrrh exerts barrier-stabilising and TNFα-antagonising effects in human intestinal epithelial cell models via inhibition of PI3K and STAT6 signalling. This suggests therapeutic application of myrrh in intestinal diseases associated with barrier defects and inflammation.
Authors: Michael J Rosen; Mark R Frey; M Kay Washington; Rupesh Chaturvedi; Lindsay A Kuhnhein; Poojitha Matta; Frank L Revetta; Keith T Wilson; D Brent Polk Journal: Inflamm Bowel Dis Date: 2011-02-09 Impact factor: 5.325
Authors: H-J Epple; T Schneider; H Troeger; D Kunkel; K Allers; V Moos; M Amasheh; C Loddenkemper; M Fromm; M Zeitz; J-D Schulzke Journal: Gut Date: 2008-10-20 Impact factor: 23.059
Authors: P Dhawan; R Ahmad; R Chaturvedi; J J Smith; R Midha; M K Mittal; M Krishnan; X Chen; S Eschrich; T J Yeatman; R C Harris; M K Washington; K T Wilson; R D Beauchamp; A B Singh Journal: Oncogene Date: 2011-03-07 Impact factor: 9.867
Authors: Fábia Daniela Lobo de Sá; Eduard Butkevych; Praveen Kumar Nattramilarasu; Anja Fromm; Soraya Mousavi; Verena Moos; Julia C Golz; Kerstin Stingl; Sophie Kittler; Diana Seinige; Corinna Kehrenberg; Markus M Heimesaat; Stefan Bereswill; Jörg-Dieter Schulzke; Roland Bücker Journal: Int J Mol Sci Date: 2019-09-28 Impact factor: 5.923
Authors: F D Lobo de Sá; M M Heimesaat; S Bereswill; P K Nattramilarasu; J D Schulzke; R Bücker Journal: Front Pharmacol Date: 2021-04-15 Impact factor: 5.810
Authors: Massimiliano G Bianchi; Martina Chiu; Giuseppe Taurino; Furio Brighenti; Daniele Del Rio; Pedro Mena; Ovidio Bussolati Journal: Nutrients Date: 2019-09-21 Impact factor: 5.717